Understanding the drivers behind disease with the 100,000 Genomes Project
Venetoclax for elderly AML patients
Highlights from the International Symposium on Acute Leukemias (ISAL) 2017 in Munich
What are the drivers of leukemia?
Can genetic abnormalities be targeted in MM?